Lataa...
Will the Evolution of Overactive Bladder Delivery Systems Increase Patient Compliance?
The negative impact of overactive bladder (OAB) on daily quality of life drives the large market of pharmacotherapy targeted at symptoms of urinary frequency and urgency, with or without urinary urge incontinence. Currently, the primary pharmacologic treatment modality is aimed at modulation of the...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MedReviews, LLC
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2725305/ https://ncbi.nlm.nih.gov/pubmed/19680525 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|